Your email has been successfully added to our mailing list.

×
0.0166537567776917 0.0166537567776917 0.0166537567776917 0.0166537567776917 0.00697134004647559 0.00890782339271884 0.0166537567776917 0.0147172734314486
Stock impact report

NICE Enables Access to First Treatment That Targets the Underlying Pathophysiology of Rare Disease X-Linked Hypophosphataemia (XLH) in Adults1 [Yahoo! Finance]

KIRIN HLDGS CO LTD S/ADR (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
Company Research Source: Yahoo! Finance
treatment of adults living with X-linked hypophosphataemia (XLH) in England, Wales and Northern Ireland LONDON, June 21, 2024 BUSINESS WIRE )--Adults living with the rare disease X-linked hypophosphataemia (XLH) in England, Wales and Northern Ireland will now have access to the first available treatment to tackle the underlying cause of XLH following NICE's decision to recommend burosumab (marketed as Crysvita) to treat adults who have a confirmed diagnosis of XLH, following a new access deal. This decision ensures equal access to burosumab across the UK, as adults living with XLH in Scotland have been able to access burosumab on the NHS since March 2023, following approval by the Scottish Medicines Consortium (SMC) through their ultra-orphan pathway. Burosumab is also available for eligible children and adolescents in all four UK nations. Initially, NICE published an interim negative decision in its Appraisal Consultation Document (ACD). Following constructive engagement betwee Show less Read more
Impact Snapshot
Event Time:
KNBWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for KNBWY alerts
Opt-in for
KNBWY alerts

from News Quantified
Opt-in for
KNBWY alerts

from News Quantified